Exact Mass: 474.1638226
Exact Mass Matches: 474.1638226
Found 141 metabolites which its exact mass value is equals to given mass value 474.1638226,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose
Constituent in cell wall polysaccharide of immature barley plants. Isolated from the enzymatic hydrolysates of tamarind polysaccharide. alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose is found in cereals and cereal products and fruits. alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose is found in cereals and cereal products. Constituent in cell wall polysaccharide of immature barley plants. It is isolated from the enzymatic hydrolysates of tamarind polysaccharide.
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is found in fruits. D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is isolated from the hydrolysate of the gum of Spondias dulcis (ambarella). Isolated from the hydrolysate of the gum of Spondias dulcis (ambarella). D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is found in fruits.
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is a constituent of sage (Salvia officinalis) leaf. Constituent of sage (Salvia officinalis) leaf [DFC]. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices.
a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose
Residue present in tomato oligosaccharides. a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose is found in garden tomato. a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose is found in garden tomato. Residue present in tomato oligosaccharides.
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-prop-2-enyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-3,4,5-triol
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol
2-phenylpropionyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
4-(3-hydroxyprop-1-enyl)-2-methoxyphenyl 6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranoside|coniferyl alcohol 4-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|ligusinenoside A
1-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin A
alpha-L-Araf-(1 -> 4)-beta-D-Galp-(1 -> 6)-alphabeta-D-Galp
O-beta-D-Galactopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-xylose
2-(3,4-dihydroxy-4-hydroxymethyltetrahydrofuran-2-yl-oxymethyl)-6-[3-(4-hydroxy-3-methoxyphenyl)allyloxy]tetrahydropyran-3,4,5-triol|coniferyl 9-O-[beta-D-apiofuranosyl(1->6)]-O-beta-D-glucopyranoside
benzoic acid methyl ester 4-O-(3-O-methyl-alpha-L-rhamnopyranosyl)-(1->2)-beta-D-allopyranoside|keteleeroside C
3-methoxy-4-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosylpropiophenone
3-methoxy-4-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosylpropiophenone
1-O-isopropyl-[5-O-(4-hydroxybenzoyl)-beta-D-apiofuranosyl]-(1?2)-beta-D-glucopyranoside|clausenoside A
4-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin B
junipercomnoside E|trans-coniferyl alcohol 9-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside
6-O-beta-D-glucopyranosyl-2-O-(2-phenylpropionyl)-D-glucose
Coniferin 2-O-beta-D-apiofuranoside|coniferyl alcohol 4-O-beta-apiofuranosyl-(1->2)-beta-glucopyranoside|coniferylalcohol-4-O-2)>glucoside
O-beta-D-Galactopyranosyl-(1 - > 6)-O-beta-D-galactopyranosyl-(1 - > 3)-L-arabinose|O3-(O6-beta-D-Galactopyranosyl-beta-D-galactopyranosyl)-L-arabinose
C21H30O12_beta-D-Glucopyranoside, 2-hydroxy-4-(2-propen-1-yl)phenyl 6-O-beta-D-glucopyranosyl
C21H30O12_4-Allyl-2-(beta-D-glucopyranosyloxy)phenyl beta-D-glucopyranoside
C21H30O12_4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol_major
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone_major
Cys Cys His Ile
Cys Cys His Leu
Cys Cys Ile His
Cys Cys Leu His
Cys His Cys Ile
Cys His Cys Leu
Cys His Ile Cys
Cys His Leu Cys
Cys Ile Cys His
Cys Ile His Cys
Cys Leu Cys His
Cys Leu His Cys
Asp Asp Glu Pro
C18H26N4O11 (474.15980060000004)
Asp Asp Pro Glu
C18H26N4O11 (474.15980060000004)
Asp Glu Asp Pro
C18H26N4O11 (474.15980060000004)
Asp Glu Pro Asp
C18H26N4O11 (474.15980060000004)
Asp Pro Asp Glu
C18H26N4O11 (474.15980060000004)
Asp Pro Glu Asp
C18H26N4O11 (474.15980060000004)
Glu Asp Asp Pro
C18H26N4O11 (474.15980060000004)
Glu Asp Pro Asp
C18H26N4O11 (474.15980060000004)
Glu Pro Asp Asp
C18H26N4O11 (474.15980060000004)
Gly His Met Met
Gly Met His Met
Gly Met Met His
His Cys Cys Ile
His Cys Cys Leu
His Cys Ile Cys
His Cys Leu Cys
His Gly Met Met
His Ile Cys Cys
His Leu Cys Cys
His Met Gly Met
His Met Met Gly
Ile Cys Cys His
Ile Cys His Cys
Ile His Cys Cys
Leu Cys Cys His
Leu Cys His Cys
Leu His Cys Cys
Met Gly His Met
Met Gly Met His
Met His Gly Met
Met His Met Gly
Met Met Gly His
Met Met His Gly
Pro Asp Asp Glu
C18H26N4O11 (474.15980060000004)
Pro Asp Glu Asp
C18H26N4O11 (474.15980060000004)
Pro Glu Asp Asp
C18H26N4O11 (474.15980060000004)
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose
alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose
a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose
4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-?-L-mannopyranosyl)-?-D-glucopyranoside
Picloxydine
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
flecainide acetate
C19H24F6N2O5 (474.15893259999996)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
benzene-1,3-dicarboxylic acid,furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol,propane-1,2-diol
alpha-D-xylosyl-(1->6)-beta-D-glucosyl-(1->4)-beta-D-glucose
alpha-D-mannosyl-(1->6)-[beta-D-xylosyl-(1->2)]-beta-D-mannose
alpha-L-arabinosyl-(1->3)-beta-D-galactosyl-(1->6)-D-galactose
N-[(2R,3S,6S)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-[(2R,4aS,12aS)-8-[[(3,5-difluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[4-[[4-(3-cyanobenzoyl)piperazin-1-yl]methyl]phenyl]-4-methylbenzenesulfonamide
MX69
C27H26N2O4S (474.16131960000007)
MX69 is an inhibitor of MDM2/XIAP, used for cancer treatment.
(2r,3r,4s,5r,6s)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)-6-{4-[(1e)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenoxy}oxane-3,5-diol
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2s)-2-phenylpropanoate
{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[3,4-dihydroxy-5-(5-methyl-2,4-dioxo-3h-pyridin-1-yl)oxolan-2-yl]acetic acid
C18H26N4O11 (474.15980060000004)